The Brave New World of Early Treatment of Multiple Sclerosis: Using the Molecular Biomarkers CXCL13 and Neurofilament Light to Optimize Immunotherapy
Article in Biomedicines (August 2022)
The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.
Article in Biomedicines (August 2022)
Article in Frontiers in Immunology (October 2021)
Article in Frontiers in Immunology (March 2021)